Eliem Therapeutics ELYM 深 沪
等待开盘 08-05 09:30:00 美东时间
5.11
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 5.11
- 总市值 14.09万
- 52周最高 11.55
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.35
- 委 比 0.00%
- 总股本 2.76万
- 历史最高 29.69
- 量 比 0
- 振 幅 0.00%
- 历史最低 2.21
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tango Therapeutics Appoints Robert Azelby to Board of Directors
Tango Therapeutics appoints Robert Azelby to its Board of Directors. With over 30 years of biopharmaceutical leadership, Azelby brings expertise in oncology commercialization and corporate strategy. His addition coincides with the advancement of vopimetostat, a potential PRMT5 inhibitor for pancreatic cancer, toward late-stage development. Azelby's experience will support Tango's mission to transform care for patients with MTAP-deleted cancers.
06-22 20:05
Eliem Therapeutics GAAP EPS of -$0.13 beats by $0.02
Eliem Therapeutics press release (NASDAQ:CLYM): Q4 GAAP EPS of -$0.13 beats by $0.02. Cash, cash equivalents and marketable securities were $212.5 million as of December 31, 2024, as compared to $106....
2025-03-26 04:38
Climb Bio set to join Nasdaq Biotech Index
Climb Bio (NASDAQ:CLYM) said it will be added to the Nasdaq Biotech Index. The inclusion will be effective prior to market open on December 23. More on Eliem Therapeutics Eliem Therapeutics: Recent St...
2024-12-19 20:15
Climb Bio Inc. Shifts Focus to Immune-Mediated Diseases
Eliem Therapeutics, Inc. ( ($CLYM) ) has released its Q3 earnings. Here is a br...
2024-11-14 12:40
Climb Bio names Douglas Williams as chair
Climb Bio (NASDAQ:CLYM) said it has appointed Douglas Williams as its chair. Williams will succeed Andrew Levin in the role. Williams has over 30 years of executive leadership experience in the biotec...
2024-11-11 20:11
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining around 400 points on ...
2024-08-30 01:06
Eliem Therapeutics: Executive Changes Amid Strategic Shift
Eliem Therapeutics (ELYM) just unveiled an update. Eliem Therapeutics, Inc. has...
2024-08-28 05:48
Eliem Therapeutics Names Brett Kaplan as New COO
Eliem Therapeutics (ELYM) has shared an announcement. Eliem Therapeutics, Inc. ...
2024-08-26 19:28
快讯 | Eliem Therapeutics宣布其领导团队的新成员
Eliem Therapeutics Announces Additions to Its Leadership Team
2024-08-26 19:00
Eliem Therapeutics GAAP EPS of -$1.81
Eliem Therapeutics press release (NASDAQ:ELYM): Q2 GAAP EPS of -$1.81. Cash and cash equivalents were $223.1 million as of June 30, 2024, as compared to cash, cash equivalents, and marketable securiti...
2024-08-15 00:18
